Limbic selected to FDA pilot, will test voice AI therapy with Medicare enrollees
Through TEMPO, Limbic will gather real-world data on outcomes, safety and how patients use the service, which will eventually support its application when it is ready to seek FDA approval.
We haven't written up this one. Fierce Healthcare has the full story — the link below goes straight to it.